1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Colorectal Cancer Research Program (CRCRP) is sponsored by U.S. Department of Defense, Congressionally Directed Medical Research Programs (CDMRP). The CRCRP supports high-impact biomedical research focused on reducing morbidity and mortality of colorectal cancer, with a unique prioritization of early-onset colorectal cancer.
It covers a broad spectrum of research, including prevention, early detection, precision oncology, tumor biology, molecular/genetic risk factors, treatment optimization, survivorship, and technology-enabled patient monitoring. Priority topics include digital risk-stratification tools, telehealth-assisted diagnostics, novel biomarkers, surgical decision-support platforms, adaptive clinical trial methodologies, and disparities research.
Eligibility is broad, including academic centers, universities, non-profits, federally funded R&D centers, and for-profit entities like biotechnology and AI diagnostic firms.
Get alerted about grants like this
Get emailed when new opportunities from “U.S. Department of Defense, Congressionally Directed Medical Research Programs (CDMRP)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Academic medical centers, universities, nonprofit research institutes, federally funded R&D centers, and qualified for-profit entities including biotechnology firms, medical device companies, imaging startups, and AI-enabled diagnostic developers. Applications must articulate clinical/translational value, scientific innovation, and military health relevance. Confirm the full requirements in the official notice before applying.
Colorectal Cancer Research Program (CRCRP) is funded by U.S. Department of Defense, Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Changing Health Systems Using Evidence-based interventions to increase Colorectal Cancer Screening is sponsored by Centers for Disease Control and Prevention - National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP). This funding opportunity supports the implementation of evidence-based interventions to increase colorectal cancer screening. It aims to reduce the burden of cancer through comprehensive and coordinated approaches to policy, systems, and environmental change strategies. The program emphasizes primary prevention, early detection, addressing the needs of cancer survivors, and promoting health equity. New Mexico Department of Health previously received funding for Cancer Prevention and Control Programs.
Changing Health Systems Using Evidence-based interventions to increase Colorectal Cancer Screening is sponsored by Centers for Disease Control - NCCDPHP. This funding opportunity from the CDC aims to increase colorectal cancer screening through evidence-based interventions within health systems. While not specific to New Mexico or Mexico, it addresses a critical cancer prevention area and is open to various organizations, including nonprofits, that can implement these interventions.
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article